Twist Bioscience Corporation Common Stock (TWST) is a publicly traded Healthcare sector company. As of May 21, 2026, TWST trades at $53.94 with a market cap of $3.10B and a P/E ratio of -40.03. TWST moved +8.46% today. Year to date, TWST is +56.26%; over the trailing twelve months it is +73.60%. Its 52-week range spans $23.30 to $66.06. Analyst consensus is strong buy with an average price target of $63.43. Rallies surfaces TWST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Twist Bioscience Corporation Common Stock (TWST) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TWST moved +8.46% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $53.94 |
| Market Cap | $3.10B |
| P/E Ratio | -40.03 |
| EPS | $-1.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $66.06 |
| 52-Week Low | $23.30 |
| Volume | 1.29M |
| Avg Volume | 0 |
| Revenue (TTM) | $409.48M |
| Net Income | $-81.28M |
| Gross Margin | 52.07% |
7 analysts cover TWST: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $63.43.